Although pancreatic cancer is a difficult cancer to cure with a low survival rate, if it is strictly early stage pancreatic cancer, it can be cured. However, early stage pancreatic cancer is very difficult to detect and has few clinical symptoms, so multiple diagnostic tools and pathways are needed. The biological characteristic of pancreatic cancer is that its malignancy is very high, even if it is radically resected, we cannot say that the patient is cured, but we still talk about the three-year survival rate and five-year survival rate. Surgery is the only means of complete cure for early stage pancreatic cancer. However, pancreatic cancer in the middle and late stages is often treated with chemotherapy, radiotherapy and targeted drugs. The survival rate is 3-4 months and 6-8 months, respectively. Under the current medical treatment, early stage pancreatic cancer is treated with a combination of surgical treatment and multiple treatments, and the surgical difficulty is also very high, requiring removal of the head of the pancreas, part of the stomach, part of the intestine, all of the gallbladder, and in some cases, the spleen. There are also more complications after surgery, reduced digestive function, habitual bloating and stomach pain, digestive disorders, and possibly malnutrition. In conclusion, early stage pancreatic cancer is curable and with the improvement of medical treatment in recent years, the cure rate has been increased. However, early detection of pancreatic cancer is very difficult, and it is usually found in the middle to late stage, and with its high surgical difficulty and risk, the prospect of surgical cure is not optimistic.